
### [MONDO:0019403](http://purl.obolibrary.org/obo/MONDO_0019403)
**Label:** congenital dyserythropoietic anemia

**Subclasses:** [MONDO:0013355](http://purl.obolibrary.org/obo/MONDO_0013355) (congenital dyserythropoietic anemia type IV), [MONDO:0014285](http://purl.obolibrary.org/obo/MONDO_0014285) (anemia, congenital dyserythropoietic, type ib), [MONDO:0009134](http://purl.obolibrary.org/obo/MONDO_0009134) (congenital dyserythropoietic anemia type II), [MONDO:0009135](http://purl.obolibrary.org/obo/MONDO_0009135) (anemia, congenital dyserythropoietic, type Ia), [MONDO:0010444](http://purl.obolibrary.org/obo/MONDO_0010444) (X-linked dyserythropoetic anemia with abnormal platelets and neutropenia), [MONDO:0019031](http://purl.obolibrary.org/obo/MONDO_0019031) (thrombocytopenia with congenital dyserythropoietic anemia), [MONDO:0020337](http://purl.obolibrary.org/obo/MONDO_0020337) (congenital dyserythropoietic anemia type i), [MONDO:0007109](http://purl.obolibrary.org/obo/MONDO_0007109) (congenital dyserythropoietic anemia type III), 

**Mapped go classes:** [GO:0008584](http://purl.obolibrary.org/obo/GO_0008584) (male gonad development), [GO:0035162](http://purl.obolibrary.org/obo/GO_0035162) (embryonic hemopoiesis), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0008104](http://purl.obolibrary.org/obo/GO_0008104) (protein localization), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0000977](http://purl.obolibrary.org/obo/GO_0000977) (RNA polymerase II regulatory region sequence-specific DNA binding), [GO:0000976](http://purl.obolibrary.org/obo/GO_0000976) (transcription regulatory region sequence-specific DNA binding), [GO:0006325](http://purl.obolibrary.org/obo/GO_0006325) (chromatin organization), [GO:0045648](http://purl.obolibrary.org/obo/GO_0045648) (positive regulation of erythrocyte differentiation), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0001158](http://purl.obolibrary.org/obo/GO_0001158) (enhancer sequence-specific DNA binding), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0017053](http://purl.obolibrary.org/obo/GO_0017053) (transcriptional repressor complex), [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation), [GO:0043009](http://purl.obolibrary.org/obo/GO_0043009) (chordate embryonic development), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0097067](http://purl.obolibrary.org/obo/GO_0097067) (cellular response to thyroid hormone stimulus), [GO:0007507](http://purl.obolibrary.org/obo/GO_0007507) (heart development), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0070742](http://purl.obolibrary.org/obo/GO_0070742) (C2H2 zinc finger domain binding), [GO:0030127](http://purl.obolibrary.org/obo/GO_0030127) (COPII vesicle coat), [GO:0016236](http://purl.obolibrary.org/obo/GO_0016236) (macroautophagy), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:2001240](http://purl.obolibrary.org/obo/GO_2001240) (negative regulation of extrinsic apoptotic signaling pathway in absence of ligand), [GO:0048702](http://purl.obolibrary.org/obo/GO_0048702) (embryonic neurocranium morphogenesis), [GO:0048821](http://purl.obolibrary.org/obo/GO_0048821) (erythrocyte development), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0048797](http://purl.obolibrary.org/obo/GO_0048797) (swim bladder formation), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0055010](http://purl.obolibrary.org/obo/GO_0055010) (ventricular cardiac muscle tissue morphogenesis), [GO:0008301](http://purl.obolibrary.org/obo/GO_0008301) (DNA binding, bending), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0000139](http://purl.obolibrary.org/obo/GO_0000139) (Golgi membrane), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:0043547](http://purl.obolibrary.org/obo/GO_0043547) (positive regulation of GTPase activity), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0030502](http://purl.obolibrary.org/obo/GO_0030502) (negative regulation of bone mineralization), [GO:0001078](http://purl.obolibrary.org/obo/GO_0001078) (transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0006998](http://purl.obolibrary.org/obo/GO_0006998) (nuclear envelope organization), [GO:0002039](http://purl.obolibrary.org/obo/GO_0002039) (p53 binding), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071733](http://purl.obolibrary.org/obo/GO_0071733) (transcriptional activation by promoter-enhancer looping), [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation), [GO:2000678](http://purl.obolibrary.org/obo/GO_2000678) (negative regulation of transcription regulatory region DNA binding), [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation), [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation), [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation), [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation), [GO:0030225](http://purl.obolibrary.org/obo/GO_0030225) (macrophage differentiation), [GO:0033690](http://purl.obolibrary.org/obo/GO_0033690) (positive regulation of osteoblast proliferation), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0060319](http://purl.obolibrary.org/obo/GO_0060319) (primitive erythrocyte differentiation), [GO:0008156](http://purl.obolibrary.org/obo/GO_0008156) (negative regulation of DNA replication), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0006888](http://purl.obolibrary.org/obo/GO_0006888) (ER to Golgi vesicle-mediated transport), [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation), [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation), [GO:0001085](http://purl.obolibrary.org/obo/GO_0001085) (RNA polymerase II transcription factor binding), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0032993](http://purl.obolibrary.org/obo/GO_0032993) (protein-DNA complex), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0001047](http://purl.obolibrary.org/obo/GO_0001047) (core promoter binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0010559](http://purl.obolibrary.org/obo/GO_0010559) (regulation of glycoprotein biosynthetic process), [GO:0097028](http://purl.obolibrary.org/obo/GO_0097028) (dendritic cell differentiation), [GO:0031497](http://purl.obolibrary.org/obo/GO_0031497) (chromatin assembly), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0035854](http://purl.obolibrary.org/obo/GO_0035854) (eosinophil fate commitment), [GO:0031490](http://purl.obolibrary.org/obo/GO_0031490) (chromatin DNA binding), [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0060218](http://purl.obolibrary.org/obo/GO_0060218) (hematopoietic stem cell differentiation), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development), [GO:0035050](http://purl.obolibrary.org/obo/GO_0035050) (embryonic heart tube development), [GO:0045637](http://purl.obolibrary.org/obo/GO_0045637) (regulation of myeloid cell differentiation), [GO:0060215](http://purl.obolibrary.org/obo/GO_0060215) (primitive hemopoiesis), [GO:0003400](http://purl.obolibrary.org/obo/GO_0003400) (regulation of COPII vesicle coating), [GO:0060975](http://purl.obolibrary.org/obo/GO_0060975) (cardioblast migration to the midline involved in heart field formation), [GO:0060216](http://purl.obolibrary.org/obo/GO_0060216) (definitive hemopoiesis), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0010725](http://purl.obolibrary.org/obo/GO_0010725) (regulation of primitive erythrocyte differentiation), [GO:0048873](http://purl.obolibrary.org/obo/GO_0048873) (homeostasis of number of cells within a tissue), [GO:0010724](http://purl.obolibrary.org/obo/GO_0010724) (regulation of definitive erythrocyte differentiation), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0012507](http://purl.obolibrary.org/obo/GO_0012507) (ER to Golgi transport vesicle membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0012505](http://purl.obolibrary.org/obo/GO_0012505) (endomembrane system), 

**Class expressions from DL-Learner:**

- [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation) 54.17%
- Thing 53.84%
- [GO:0030099](http://purl.obolibrary.org/obo/GO_0030099) (myeloid cell differentiation) 51.56%
- [GO:0070527](http://purl.obolibrary.org/obo/GO_0070527) (platelet aggregation) 51.39%
- [GO:0061026](http://purl.obolibrary.org/obo/GO_0061026) (cardiac muscle tissue regeneration) 51.39%
- [GO:0060319](http://purl.obolibrary.org/obo/GO_0060319) (primitive erythrocyte differentiation) 51.39%
- [GO:0030224](http://purl.obolibrary.org/obo/GO_0030224) (monocyte differentiation) 51.39%
- [GO:0030223](http://purl.obolibrary.org/obo/GO_0030223) (neutrophil differentiation) 51.39%
- [GO:0030222](http://purl.obolibrary.org/obo/GO_0030222) (eosinophil differentiation) 51.39%
- [GO:0030221](http://purl.obolibrary.org/obo/GO_0030221) (basophil differentiation) 51.39%
- [GO:0030220](http://purl.obolibrary.org/obo/GO_0030220) (platelet formation) 51.39%
- [GO:0030219](http://purl.obolibrary.org/obo/GO_0030219) (megakaryocyte differentiation) 51.39%
- [GO:0030218](http://purl.obolibrary.org/obo/GO_0030218) (erythrocyte differentiation) 51.39%
- [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation) and [GO:0048856](http://purl.obolibrary.org/obo/GO_0048856) (anatomical structure development) 51.39%
- [GO:0030851](http://purl.obolibrary.org/obo/GO_0030851) (granulocyte differentiation) and [GO:0048468](http://purl.obolibrary.org/obo/GO_0048468) (cell development) 51.39%


